← Every company

Viatris Inc Lobbying

What Viatris Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.

VTRS on carbonthat →
Disclosed spend
$1.2M
across every filing on file
Filings
8
Years covered
1
Firms retained
4

What it lobbies about

PharmacyTrade (domestic/foreign)Health IssuesCopyright/Patent/TrademarkFinancial Institutions/Investments/SecuritiesDefense

8 filings

Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.

PeriodLobbying for themDisclosed
20261st Quarter (Jan 1 - Mar 31)VIATRIS INC.Health IssuesCopyright/Patent/Trademark$490K
20262nd Quarter (Apr 1 - June 30)VIATRIS INC.Health IssuesCopyright/Patent/Trademark$360K
20261st Quarter (Jan 1 - Mar 31)FEROX STRATEGIESPharmacyTrade (domestic/foreign)$70K
20262nd Quarter (Apr 1 - June 30)FEROX STRATEGIESPharmacyTrade (domestic/foreign)$70K
20262nd Quarter (Apr 1 - June 30)S-3 GROUPHealth IssuesCopyright/Patent/Trademark$60K
20261st Quarter (Jan 1 - Mar 31)S-3 GROUPHealth IssuesCopyright/Patent/Trademark$60K
20262nd Quarter (Apr 1 - June 30)HOLLAND & KNIGHT LLPPharmacy$50K
20261st Quarter (Jan 1 - Mar 31)HOLLAND & KNIGHT LLPPharmacy$50K

A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.

More on VTRS

Related datasets